| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in investing activities | -22,705 | -37,965 |
| Proceeds from exercise of stock options | 0 | 0 |
| Proceeds from issuance of common stock in private placement, net of issuance costs | 0 | 0 |
| Net cash provided by financing activities | 0 | 0 |
| Effect of exchange rate changes on cash and cash equivalents | 0 | 0 |
| Net change in cash and cash equivalents | -61,426 | -64,547 |
| Cash and cash equivalents at beginning of period | 87,229 | - |
| Cash and cash equivalents at end of period | 25,803 | - |
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)